Andrea Lora Kossler
Overview
Explore the profile of Andrea Lora Kossler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Men C, Amarikwa L, Pham B, Sears C, Clauss K, Lee B, et al.
Ophthalmic Plast Reconstr Surg
. 2025 Jan;
41(1):111-112.
PMID: 39752221
No abstract available.
2.
Quiruz L, Yavari N, Kikani B, Gupta A, Wai K, Kossler A, et al.
Am J Ophthalmol
. 2024 Nov;
270():278-279.
PMID: 39528009
No abstract available.
3.
Quiruz L, Yavari N, Kikani B, Gupta A, Wai K, Kossler A, et al.
Am J Ophthalmol
. 2024 Sep;
268:348-359.
PMID: 39271090
Purpose: Assessing immune-related ocular toxicities from immune checkpoint inhibitors (ICIs) is crucial, though rare. This study, utilizing real-world data, examines the occurrence of ophthalmic immune-related adverse events (irAEs) after ICI...
4.
Phansalkar R, Lu T, Alyono J, Lee J, Dosiou C, Kossler A
Ophthalmic Plast Reconstr Surg
. 2023 Mar;
39(4):e101-e104.
PMID: 36877549
Teprotumumab has been shown to be effective in the treatment of thyroid eye disease, a potentially vision-threatening condition. Adverse events, including sensorineural hearing loss, have been associated with teprotumumab. The...
5.
Kossler A, Douglas R, Dosiou C
J Clin Endocrinol Metab
. 2022 Nov;
107(Suppl_1):S36-S46.
PMID: 36346685
Context: Thyroid eye disease (TED) is a sight-threatening and debilitating autoimmune condition, with limited therapies available, that often poses diagnostic and therapeutic challenges. In recent years, the treatment landscape has...
6.
Amarikwa L, Mohamed A, Kim S, Kossler A, Dosiou C
J Clin Endocrinol Metab
. 2022 Oct;
108(4):858-864.
PMID: 36300333
Context: Graves orbitopathy (GO) or thyroid eye disease is a potentially sight-threatening and disfiguring autoimmune disease. Teprotumumab is a monoclonal antibody against the insulin-like growth factor-I receptor that was recently...
7.
Mohamed A, Tzoulis P, Kossler A, Dosiou C
J Clin Endocrinol Metab
. 2022 Oct;
108(4):979-985.
PMID: 36251747
Context: Occurrence of Graves' disease (GD) has been reported following SARS-CoV-2 vaccine administration, but little is known about thyroid eye disease (TED) after SARS-CoV-2 vaccination. Objective: We describe 2 cases...
8.
Hung J, Chen K, Perera C, Chiu H, Hsu C, Myung D, et al.
J Pers Med
. 2022 Feb;
12(2).
PMID: 35207771
The aim of this study is to develop an AI model that accurately identifies referable blepharoptosis automatically and to compare the AI model's performance to a group of non-ophthalmic physicians....
9.
Charlson E, Pepper J, Kossler A
Ophthalmic Plast Reconstr Surg
. 2021 Oct;
38(1):e17-e19.
PMID: 34652308
Corneal neurotization is a fast-evolving surgical procedure for sensory reinnervation in neurotrophic keratopathy. After neurotization, prior reports document return of corneal sensation on average 8 months after surgery with 38 ...
10.
Chandramohan A, Sears C, Huang L, Beres S, Fredrick D, Kossler A
J AAPOS
. 2021 Oct;
25(6):358-360.
PMID: 34597781
We report the case of a 4-month-old boy diagnosed with DiGeorge syndrome with novel ocular features. The patient was diagnosed through genetic testing, with a noted 22q11.2 deletion, and had...